In tamoxifen-resistant ER+ breast cancer patients, Notch 1 and oestrogen receptor-1 (ESR1) showed reciprocal regulation as well as Notch 1 overexpression; potentially indicating Notch 1′s involvement in endocrine resistance [218]. This evidence concerns the gene ESR1 and breast cancer.